Summit Therapeutics Inc vs Wolfspeed Inc — how do they compare? Summit Therapeutics Inc trades at $15.38 (market cap $12.06B), while Wolfspeed Inc trades at $31.25 (market cap $1.57B). The key difference: Summit Therapeutics Inc is far larger — about 7.7× Wolfspeed Inc's market cap, and Wolfspeed Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| SMMT | WOLF | |
|---|---|---|
Market Cap | $12.06B | $1.57B |
Sector | Health | Technology |
52-Week High | $26.98 | $73.68 |
52-Week Low | $12.55 | $1.19 |
Enterprise Value | $11.39B | $2.22B |
Trailing returns across standard periods
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →